Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease
This study has been completed.
Study NCT00078611   Information provided by Elan Pharmaceuticals
First Received: March 1, 2004   Last Updated: October 26, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial